ATP 检测市场 - 全球产业规模、份额、趋势、机会和预测，按类型、应用、最终用途、地区和竞争细分，2020-2030 年

2024 年，全球 ATP 检测市场价值为 33.7 亿美元，预计到 2030 年将达到 53.0 亿美元，预测期内复合年增长率为 7.78%。这种成长的推动因素包括对快速、灵敏检测方法的需求、製药和生物技术研究应用的扩展、监管审批的增加以及慢性病盛行率的上升。这些因素凸显了 ATP 检测在医疗保健、研究和工业领域的重要作用，支持个人化医疗、药物发现、环境监测、食品安全和品质检测以及疾病管理方面的进步。

市场概况
预测期	2026-2030
2024 年市场规模	33.7亿美元
2030 年市场规模	53亿美元
2025-2030 年复合年增长率	7.78%
成长最快的细分市场	ATP 发光检测
最大的市场	北美洲

ATP 测定通常用于测量细胞活力、细胞毒性和代谢活动，这对于了解乙型肝炎和丙型肝炎等病毒感染的病理学至关重要。细胞健康和损伤。根据世界卫生组织 (WHO) 2023 年 7 月发布的报告，西太平洋地区约有 1.16 亿人感染乙型肝炎，1,000 万人感染C型肝炎。 79岁的成年人中有10.5%患有糖尿病，其中近一半人不知道自己的病情。这些感染可导致严重的疾病，例如癌症、肝硬化和与病毒性肝炎相关的死亡。此外，每年约有 300 万新感染病例，其中相当一部分未被发现，特别是在西太平洋区域。

主要市场驱动因素

製药和生物技术产业需求不断成长

食品安全和卫生标准意识不断增强

ATP 测定方法的技术进步

主要市场挑战

缺乏 ATP 检测特异性

监管合规性和标准化问题

主要市场趋势

越来越多地采用快速测试解决方案

ATP 检测中智慧技术的集成

细分市场洞察

类型洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球 ATP 检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（发光 ATP 测定、酶 ATP 测定、生物发光共振能量转移 (BRET) ATP 测定、基于细胞的 ATP 测定、其他）
  • 按应用（药物发现和开发、临床诊断、环境测试、食品安全和品质测试、其他）
  • 按最终用途（製药和生物技术公司、学术和研究机构、医院和诊断实验室）
  • 按地区
  • 按公司划分 (2024)
• 市场地图

第 6 章：北美 ATP 检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用途
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲 ATP 检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用途
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区 ATP 检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用途
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 南
  • 澳洲

第 9 章：南美洲 ATP 检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用途
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲 ATP 检测市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型
  • 按申请
  • 按最终用途
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品/服务的威胁

第14章：竞争格局

• Thermo Fisher Scientific Inc.
• Promega Corporation
• PerkinElmer Inc.
• Becton, Dickinson and Company (BD)
• Lonza Group AG
• DH Life Sciences, LLC.
• Abcam Limited
• Quest Diagnostics Incorporated
• BIOMERIEUX SA
• 3M Company

第 15 章：策略建议

第16章调查会社について・免责事项

Global ATP Assays Market was valued at USD 3.37 billion in 2024 and is expected to reach USD 5.30 billion by 2030 with a CAGR of 7.78% during the forecast period. This growth is driven by the need for rapid and sensitive detection methods, the expansion of pharmaceutical and biotechnology research applications, increasing regulatory approvals, and the rising prevalence of chronic diseases. These factors highlight the essential role of ATP assays across healthcare, research, and industrial sectors, supporting advancements in personalized medicine, drug discovery, environmental monitoring, food safety and quality testing, as well as disease management.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.37 Billion
Market Size 2030	USD 5.30 Billion
CAGR 2025-2030	7.78%
Fastest Growing Segment	Luminometric ATP Assays
Largest Market	North America

ATP assays are commonly used to measure cellular viability, cytotoxicity, and metabolic activity, which are crucial in understanding the pathology of viral infections like hepatitis B and C. These infections impact liver cells, and ATP assays can help quantify cell health and damage during infection. According to a report released by the World Health Organization (WHO) in July 2023, In the western -pacific region approximately 116 million people are affected by hepatitis B and 10 million by hepatitis C. Additionally, According to the IDF Diabetes Atlas (2021), 10.5% of adults aged 20 to 79 have diabetes, with nearly half of them unaware of their condition. These infections can result in serious conditions such as cancer, liver cirrhosis, and deaths related to viral hepatitis. Additionally, around 3 million new infections occur each year, with a significant number going undetected, particularly in the Western Pacific Region.

Key Market Drivers

Growing Demand in Pharmaceutical and Biotechnology Industries

The pharmaceutical and biotechnology sectors are key drivers of the ATP assay market. As these industries expand, there is an increasing need for effective contamination control and microbial monitoring. ATP assays provide rapid and reliable methods for detecting biological contamination in manufacturing processes, ensuring compliance with regulatory standards. The rise in biopharmaceutical production, especially with the growing trend toward personalized medicine, necessitates stringent quality control measures. Companies are increasingly adopting ATP assays to monitor cleanliness in production environments, thereby ensuring product safety and efficacy.

The shift toward automation and real-time monitoring in laboratory and production environments enhances the demand for ATP assays. These assays enable quick decision-making, reducing downtime and improving operational efficiency. The need for faster turnaround times in drug development and production further propels the market, making ATP assays an essential tool for industry stakeholders.

Rising Awareness of Food Safety and Hygiene Standards

The global focus on food safety and hygiene has intensified in recent years, driven by heightened consumer awareness and regulatory requirements. ATP assays play a crucial role in the food and beverage industry by providing a rapid method for assessing cleanliness and microbial load on surfaces, equipment, and food products. This is particularly relevant in the context of outbreaks of foodborne illnesses, where swift action is essential to prevent public health crises.

Food manufacturers and processors are increasingly implementing ATP assays as part of their hygiene monitoring programs. The ability to obtain immediate results allows companies to take corrective actions promptly, ensuring compliance with food safety regulations and protecting brand reputation. As governments and regulatory bodies continue to emphasize the importance of food safety, the demand for effective monitoring tools like ATP assays is expected to grow significantly. The 2022 WHO report indicates that food contamination impacts approximately 600 million individuals worldwide, contributing to over 200 different diseases each year. This includes serious illnesses like diarrhea, which alone results in 420,000 fatalities and a loss of 33 million healthy life years.

As awareness of food safety and hygiene standards rises globally, there is an increasing emphasis on implementing effective monitoring and prevention strategies. Consumers are becoming more conscious of the importance of safe food practices, leading to heightened demand for transparency in food production and processing. This shift is prompting food manufacturers and service providers to adopt rigorous safety measures, including the use of advanced technologies like ATP assays for contamination detection.

Technological Advancements in ATP Assay Methods

Innovation in ATP assay technology is another critical driver of market growth. The development of more sensitive, user-friendly, and automated systems has broadened the applications of ATP assays across various industries. Advances such as portable devices and smartphone-based assays have made ATP testing more accessible, enabling on-site testing and immediate results.

Improvements in assay sensitivity and specificity have enhanced the reliability of ATP tests, making them suitable for more diverse applications, including clinical diagnostics and environmental monitoring. As industries continue to seek efficient and effective contamination detection methods, the trend toward technological enhancement in ATP assays is likely to sustain market momentum.

Key Market Challenges

Lack of ATP Assay Specificity

While ATP assays are widely used for monitoring biological contamination, one of their significant challenges is their lack of specificity. The presence of ATP does not necessarily indicate microbial contamination, as it can be derived from both living and dead cells, as well as from non-biological sources. This can lead to false positives, making it difficult to ascertain the actual contamination risk.

In sectors such as healthcare and pharmaceuticals, where the consequences of contamination can be dire, relying solely on ATP assays may not be sufficient. Companies must combine ATP testing with other methods, such as culture-based techniques or molecular methods, to obtain a more accurate picture of contamination levels. This requirement for complementary testing can increase costs and complexity for end-users.

Regulatory Compliance and Standardization Issues

Regulatory compliance is a critical concern in industries using ATP assays, especially in pharmaceuticals and food safety. The lack of standardized guidelines for ATP testing can lead to variability in results and interpretations, complicating compliance efforts. Different regions may have varying regulatory requirements, making it challenging for global companies to implement a uniform testing strategy.

The evolving nature of regulations can necessitate continuous updates to testing protocols and equipment, increasing operational costs for companies. Ensuring that personnel are adequately trained in the proper use of ATP assays and in interpreting results is also essential, adding another layer of complexity to compliance efforts.

Key Market Trends

Increasing Adoption of Rapid Testing Solutions

The trend toward rapid testing solutions is reshaping the landscape of ATP assays. Industries are increasingly prioritizing speed without compromising accuracy. According to the 2021 report by the National Health Commission, China recorded 2,711,785 cases of 27 Class A and B notifiable infectious diseases, corresponding to an incidence rate of 192.58 per 100,000 population. The high prevalence of infectious diseases underscores the critical need for advanced diagnostic and research tools, including ATP assays, which are instrumental in studying pathogen-host interactions and evaluating therapeutic efficacy. These assays play a key role in detecting cellular responses to infections, aiding in drug discovery and enhancing disease management strategies.

Rapid ATP tests allow for quicker decision-making, which is critical in time-sensitive environments such as hospitals and food processing plants. The ability to receive immediate results facilitates faster corrective actions and minimizes potential risks associated with contamination.

As businesses face pressures to enhance operational efficiency and maintain high safety standards, the demand for rapid ATP testing solutions is likely to continue growing. This trend is further supported by advancements in technology that enable more streamlined testing processes, including automation and digital integration, making it easier for organizations to implement ATP testing as part of their routine monitoring practices.

Integration of Smart Technologies in ATP Assays

The integration of smart technologies, such as IoT and AI, into ATP assays is emerging as a significant trend. These technologies enhance the capabilities of traditional ATP assays by enabling remote monitoring and data analytics. IoT-enabled ATP testing devices can transmit data in real-time to centralized systems, allowing for comprehensive monitoring across multiple sites.

AI algorithms can analyze the data collected from ATP assays, identifying patterns and predicting potential contamination risks. This integration not only improves the efficiency of contamination monitoring but also aids in proactive decision-making. As industries continue to embrace digital transformation, the use of smart technologies in ATP assays will likely become more prevalent, driving the market forward and enhancing overall safety and quality assurance efforts.

Segmental Insights

Type Insights

Based on the type, the luminometric ATP assays held the largest market share during the forecast period. This dominance is attributed to their high sensitivity, versatility across various applications, quick detection capabilities, and alignment with regulatory standards. As industries increasingly focus on improving quality control and safety protocols, luminometric ATP assays play a crucial role in maintaining product integrity, ensuring environmental health, and safeguarding public safety across diverse sectors worldwide.

A notable example is the Luminescent ATP Detection Assay Kit developed by Abcam plc. This kit determines cellular ATP levels by lysing cell samples, introducing the luciferase enzyme and luciferin, and then measuring the resulting light emitted using a luminometer. Its applications are extensive, including assessing cell viability, monitoring metabolic activity, evaluating cytotoxicity in drug development, and supporting research in fields such as cancer, microbiology, and biochemistry.

As the demand for real-time and accurate monitoring continues to grow, the importance of luminometric ATP assays in laboratory settings and industrial processes will likely increase. Their ability to provide rapid feedback makes them invaluable for ensuring compliance with safety standards and optimizing operational efficiencies. As research progresses, the versatility and reliability of luminometric ATP assays will further cement their role in advancing scientific discovery and public health initiatives.

Regional Insights

North America is dominating the ATP assays market in 2024 due to several factors, including its advanced healthcare infrastructure, which features state-of-the-art laboratories and a strong emphasis on research and development. The region's stringent food safety regulations, enforced by agencies like the FDA and USDA, have heightened awareness and implementation of hygiene monitoring practices in the food and beverage industry, driving the adoption of ATP assays to ensure compliance. North America's leadership in pharmaceutical and biotechnology research fuels the demand for reliable testing methods, particularly as institutions invest in new technologies. The COVID-19 pandemic has further increased awareness of hygiene and infection control, leading to a surge in demand for effective contamination detection across various sectors. Coupled with ongoing technological innovations such as portable devices and automation, these factors collectively position North America as a key player in the ATP assays market.

Key Market Players

• Thermo Fisher Scientific Inc.
• Promega Corporation
• PerkinElmer Inc.
• Becton, Dickinson and Company (BD)
• Lonza Group AG
• DH Life Sciences, LLC.
• Abcam Limited
• Quest Diagnostics Incorporated
• BIOMERIEUX S.A.
• 3M Company

Report Scope:

In this report, the Global ATP Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ATP Assays Market, By Type:

• Luminometric ATP Assays
• Enzymatic ATP Assays
• Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
• Cell-based ATP Assays
• Others

ATP Assays Market, By Application:

• Drug Discovery and Development
• Clinical Diagnostics
• Environmental Testing
• Food Safety and Quality Testing
• Others

ATP Assays Market, By End Use:

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospital and Diagnostics Laboratories

ATP Assays Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global ATP Assays Market.

Available Customizations:

Global ATP Assays market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global ATP Assays Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Luminometric ATP Assays, Enzymatic ATP Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, Cell-based ATP Assays, Others)
  • 5.2.2. By Application (Drug Discovery and Development, Clinical Diagnostics, Environmental Testing, Food Safety and Quality Testing, Others)
  • 5.2.3. By End Use (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital and Diagnostics Laboratories)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America ATP Assays Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States ATP Assays Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada ATP Assays Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico ATP Assays Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe ATP Assays Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany ATP Assays Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. United Kingdom ATP Assays Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. Italy ATP Assays Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. France ATP Assays Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain ATP Assays Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia-Pacific ATP Assays Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China ATP Assays Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India ATP Assays Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan ATP Assays Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South ATP Assays Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia ATP Assays Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. South America ATP Assays Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil ATP Assays Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. Argentina ATP Assays Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. Colombia ATP Assays Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. Middle East and Africa ATP Assays Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa ATP Assays Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Saudi Arabia ATP Assays Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. UAE ATP Assays Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Promega Corporation
• 14.3. PerkinElmer Inc.
• 14.4. Becton, Dickinson and Company (BD)
• 14.5. Lonza Group AG
• 14.6. DH Life Sciences, LLC.
• 14.7. Abcam Limited
• 14.8. Quest Diagnostics Incorporated
• 14.9. BIOMERIEUX S.A.
• 14.10. 3M Company

15. Strategic Recommendations

16. About Us & Disclaimer